Guardant Health, Inc. Operating Income Loss

• Guardant Health, Inc. showed an increase of +1.4% in Operating Income Loss from 2024 to 2025.
• This data is from Guardant Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
• XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 10 years of available data (2016 to 2025), Guardant Health, Inc.'s Operating Income Loss has declined by 897.2%.
• Historical annual values: Fiscal year 2025: -$437.25 million | Fiscal year 2024: -$443.59 million | Fiscal year 2023: -$564.73 million | Fiscal year 2022: -$544.38 million | Fiscal year 2021: -$411.00 million | Fiscal year 2020: -$254.95 million | Fiscal year 2019: -$82.37 million | Fiscal year 2018: -$92.94 million | Fiscal year 2017: -$76.61 million | Fiscal year 2016: -$43.85 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026